Compare ADMA Biologics Inc (ADMA) vs iShares Core S&P 500 ETF (IVV) Price & Performance

ADMA Biologics IncTrade

iShares Core S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs iShares Core S&P 500 ETF — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while iShares Core S&P 500 ETF trades at $776.1. The key difference: iShares Core S&P 500 ETF is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

	ADMA	IVV
Market Cap	$2.22B	—
Sector	Health	Broad Market / Factor
52-Week High	$20.38	$776.81
52-Week Low	$7.60	$634.93
Enterprise Value	$2.29B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ADMA

View details →

IVV

WisdomTree U.S. Total Dividend ETF (DTD) rated 'hold' for balanced factors but overlaps 57% with S&P 500 ETFs.Seeking Alpha · 1 day agoNeutral Main Sector Rotation ETF (SECT) gets Hold rating due to weak performance versus IVV.Seeking Alpha · 4 days agoNeutral View details →

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

About iShares Core S&P 500 ETF

IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.